Search Results for "Ora Allergen Biocube"
Original Source: An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to Placebo
The purpose of this study is to evaluate the onset of action of fluticasone furoate nasal spray compared to olopatadine nasal spray and placebo nasal spray in reducing nasal allergic signs and symptoms following ragweed exposure in the Allergen BioCube (ABC) after single dose administration and six consecutive days of treatment.
Matching Channels
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms an...
Matching News
Alkor Bio Of Russia Develops 24 More Allergen Reagents For Diagnostics
Russia's Alkor Bio said it has developed 24 more allergen reagents for diagnostics, dealing with such problems such as insect, fish, fruit, vegetable and other allergies, to increase its portfolio to...
Allergen Announces The Bolt-On Acquisition Of SkinMedica
By Robert Broens: Shares of Allergen(AGN) rose some 0.9% in Friday's trading session. The multi-specialty health care company announced the acquisition of SkinMedica before the market open. The Deal...
Updated Allergen Labelling Rules Now in Effect
New allergen labelling regulations for most foods sold in Canada will take effect today.
Allergen Immunotherapy: Best Practices
Allergen immunotherapy is effective and helps to reduce patient healthcare costs, according to the most recent research. Medscape Allergy & Immunology
AllerGen awards $250,000 research fellowship aimed at developing new treatments for food allergies
Dr. Philippe Bégin, from the Centre hospitalier de l’Université de Montréal (CHUM) and the Centre hospitalier universitaire Sainte-Justine (CHU Sainte-Justine) in Montréal, Québec, has won Alle...
Allergen Immunotherapy: Views of Pulmonologists and Allergists
Why do pulmonologists shy away from allergen immunotherapy when suggesting a treatment strategy for patients with asthma? Immunotherapy
Allergen-Specific Immunotherapy for Atopic Eczema
Which atopic eczema patients benefit the most from allergen specific immunotherapy? Current Opinion in Allergy and Clinical Immunology
Circassia commences ToleroMune phase 3 trial in cat allergen-induced rhinoconjunctivitis
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the start of a pivotal phase 3 trial of its investigational ToleroMune cat allergy treatment for cat allergen-i...
Matching PubMed Articles
The diagnostic performance of allergen-molecules in comparison to allergen-extracts.
Abstract Background: This study evaluated the diagnostic performance of naturally purified allergen-molecules compared to that of allergen-extracts for house dust mite, cat dander epithelium and dog...
Molecular Approaches to Allergen Standardization.
Molecular approaches to allergen standardization include the development of purified natural or recombinant allergen standards whose structural and allergenic properties have been validated, in tandem...
Passive Immunization with Allergen-Specific Antibodies.
The induction of allergen-specific IgG antibodies has been identified as a major mechanism responsible for the reduction of allergic inflammation in allergic patients treated by allergen-specific immu...
Epicutaneous/transcutaneous allergen-specific immunotherapy: rationale and clinical trials.
PURPOSE OF REVIEW: IgE-mediated allergies, such as allergic rhinoconjunctivitis and asthma, have become highly prevalent, today affecting up to 35% of the population in industrialized countries. Aller...
Summary Background Allergen exposure may increase airway oxidative stress, which causes lipid membrane peroxidation and an increased formation of 8-isoprostane. Objective The aim of the study was to i...
